Disease Control and Gender Predict the Socioeconomic Effects of Acromegaly: A Nationwide Cohort Study
- 1 September 2020
- journal article
- research article
- Published by The Endocrine Society in Journal of Clinical Endocrinology & Metabolism
- Vol. 105 (9), 2975-2982
- https://doi.org/10.1210/clinem/dgaa405
Abstract
Context: Acromegaly is an insidious disease associated with severe somatic morbidity but data on socioeconomic status are scarce. Objective: To study the socioeconomic status in acromegaly in a population-based follow-up study. Methods: All incident cases of acromegaly (n = 576) during the period 1977-2010 were included. For every patient, 100 persons were sampled from the general population matched for date of birth and gender (comparison cohort). Cox regression and hazard ratios (HR), conditional logistic regression and linear regression with 95% confidence intervals (CI) were used. Outcome Measures: Retirement, social security benefit, annual income, cohabitation, separation, parenthood and educational level. Results: The proportion of retired individuals was significantly higher in patients with acromegaly after the time of diagnosis (HR, 1.43; 95% CI, 1.26-1.62) and also during the 5-year pre-diagnostic period (HR, 1.15; 95% CI, 1.03-1.28). More individuals with acromegaly received social security benefit compared with the comparison cohort during the initial period after the time of diagnosis. Among patients who maintained a job, the annual income was similar to the comparison cohort. Compared with the background population, cohabitation was lower (HR, 0.69; 95% CI, 0.50-0.95) as was parenthood (HR, 0.56; 95% CI, 0.39-0.80), whereas neither educational level (HR, 0.61; 95% CI, 0.35-1.06) nor separation (HR, 1.13; 95% CI, 0.86-1.47) were different. Female gender and insufficient disease control were associated with a significantly worse socioeconomic status. Conclusions: 1) Socioeconomic status is impaired in patients with acromegaly even before a diagnosis of acromegaly. 2) Females and patients without disease remission have worse outcomes. 3) Early diagnosis and effective treatment of acromegaly could be important factors in mitigating the negative impact on socioeconomic factors.Keywords
Funding Information
- Pfizer
- Alfred Benzon Foundation
This publication has 28 references indexed in Scilit:
- The Metabolic Profile in Active Acromegaly is Gender-SpecificJournal of Clinical Endocrinology & Metabolism, 2013
- Cost of Clinical Management of Acromegaly in SpainClinical Drug Investigation, 2012
- Female Gonadal Function before and after Treatment of AcromegalyJournal of Clinical Endocrinology & Metabolism, 2010
- Acromegaly and Pregnancy: A Retrospective Multicenter Study of 59 Pregnancies in 46 WomenJournal of Clinical Endocrinology & Metabolism, 2010
- Effects of octreotide exposure during pregnancy in acromegalyClinical Endocrinology, 2010
- Prevalence of mental disorders in acromegaly: a cross‐sectional study in 81 acromegalic patientsClinical Endocrinology, 2009
- Assessment of quality of life in patients with uncontrolled vs. controlled acromegaly using the Acromegaly Quality of Life Questionnaire (AcroQoL)Clinical Endocrinology, 2005
- Morbidity after Long-Term Remission for Acromegaly: Persisting Joint-Related Complaints Cause Reduced Quality of LifeJournal of Clinical Endocrinology & Metabolism, 2005
- Long-Term Biochemical Status and Disease-Related Morbidity in 53 Postoperative Patients with AcromegalyJournal of Clinical Endocrinology & Metabolism, 2004
- The Impact of Pituitary Adenoma on MorbidityPharmacoEconomics, 2000